Literature DB >> 7829645

Marked hypocholesterolemia in a case with adrenal adenoma--enhanced catabolism of low density lipoprotein (LDL) via the LDL receptors of tumor cells.

T Nakagawa1, Y Ueyama, S Nozaki, S Yamashita, M Menju, T Funahashi, K Kameda-Takemura, M Kubo, K Tokunaga, T Tanaka.   

Abstract

A 16-yr-old girl was hospitalized because of amenorrhea and virilism, and was diagnosed with an adrenal tumor on the right side. Her serum androgen levels were markedly elevated, and severe hypocholesterolemia (total cholesterol, 0.59 mmol/L) was observed. After resection of the tumor, her serum cholesterol level dramatically rose to normal, suggesting a role of this tumor in her marked hypocholesterolemia. To investigate the mechanism of hypocholesterolemia in this case, we examined the effects of dehydroepiandrosterone and dehydroepiandrosterone sulfate on the low density lipoprotein (LDL) receptor activity of fibroblasts. These hormones did not have any effect on LDL receptor activity. Northern blot analysis demonstrated that the LDL receptor messenger ribonucleic acid level of this tumor tissue was increased about 8-fold compared with that of normal adrenal cortex. The LDL receptor activity of the cultured cells established from this tumor was 2-fold higher than that of Hep G2 cells. Furthermore, the LDL receptor activity could not be down-regulated by an excessive dose of 25-hydroxycholesterol. These results suggest that increased LDL receptor activity and unrestricted uptake of LDL by the adrenal tumor may have caused the marked hypocholesterolemia in this patient.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829645     DOI: 10.1210/jcem.80.1.7829645

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

Authors:  Lacy Reynolds; Rohit S Mulik; Xiaodong Wen; Archana Dilip; Ian R Corbin
Journal:  Nanomedicine (Lond)       Date:  2014-01-07       Impact factor: 5.307

2.  Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.

Authors:  Iara F Kretzer; Durvanei A Maria; Raul C Maranhão
Journal:  Cell Oncol (Dordr)       Date:  2012-10-03       Impact factor: 6.730

3.  Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Ian R Corbin; Hui Li; Juan Chen; Sissel Lund-Katz; Rong Zhou; Jerry D Glickson; Gang Zheng
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

4.  Low Density Lipid Nanoparticles for Solid Tumor Targeting.

Authors:  Mayank Shrivastava; Aviral Jain; Arvind Gulbake; Pooja Hurkat; Neeti Jain; R Vijayraghwan; Sanjay K Jain
Journal:  Sci Pharm       Date:  2014-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.